June 16, 2025

News from the European Medicines Agency

The European Medicines Agency (EMA), the office responsible for the scientific evaluation, supervision and safety monitoring of medicines in the European Union, has been very active in the past months:

  • The Patients’ and Consumers’ Working Party (PCWP) held a meeting on April 1 and 2. The meeting was attended by Ms Otilia Stanga, IPOPI Board member and Chair of the Romanian PID patient organisation (ARPID), and Ms Leire Solis, IPOPI health policy and advocacy director. Topics in the agenda included:
    • The work of the Agency in tackling shortages of medicines (presentation 1 and presentation 2);
    • Integration of real-world evidence in regulatory decisions (presentation);
    • The plans of the Agency to launch a public consultation on patient experience data in Q4 2025 (presentation);
    • The cross-agency One Health Task Force aimed at better preventing, predicting, detecting and responding to health threats (presentation)
    • More information on the presentations and discussions can be found here.
  • Revision of the recommendations on the use of antibiotic azithromycin, aiming at optimising the use of this common antibiotic and minimising the development of antimicrobial resistance. More information here.
  • Upcoming public events: “Public webinar on shortages, putting patients first”, on November 4, 2025, online.